Search Results - "Palanimuthu, Duraippandi"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2

    Biotin Decorated Gold Nanoparticles for Targeted Delivery of a Smart-Linked Anticancer Active Copper Complex: In Vitro and In Vivo Studies by Pramanik, Anup K, Siddikuzzaman, Palanimuthu, Duraippandi, Somasundaram, Kumaravel, Samuelson, Ashoka G

    Published in Bioconjugate chemistry (21-12-2016)
    “…The synthesis and anticancer activity of a copper­(II) diacetyl-bis­(N4-methylthiosemicarbazone) complex and its nanoconjugates are reported. The copper­(II)…”
    Get full text
    Journal Article
  3. 3

    Imaging Intracellular Zinc by Using a Glyoxal Bis(4-methyl-4-phenyl-3-thiosemicarbazone) Ligand by Palanimuthu, Duraippandi, Shinde, Sridevi Vijay, Dayal, Disha, Somasundaram, Kumaravel, Samuelson, Ashoka G.

    Published in European journal of inorganic chemistry (01-07-2013)
    “…The ligand glyoxal bis(4‐methyl‐4‐phenyl‐3‐thiosemicarbazone) (GTSCH2) is shown to be a selective fluorescence “turn‐on” sensor for zinc ions (Zn2+). This…”
    Get full text
    Journal Article
  4. 4

    In Vitro and in Vivo Anticancer Activity of Copper Bis(thiosemicarbazone) Complexes by Palanimuthu, Duraippandi, Shinde, Sridevi Vijay, Somasundaram, Kumaravel, Samuelson, Ashoka G

    Published in Journal of medicinal chemistry (14-02-2013)
    “…Neutral and cationic copper bis(thiosemicarbazone) complexes bearing methyl, phenyl, and hydrogen, on the diketo-backbone of the ligand have been synthesized…”
    Get full text
    Journal Article
  5. 5

    Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes by Anjum, Rukhsana, Palanimuthu, Duraippandi, Kalinowski, Danuta S, Lewis, William, Park, Kyung Chan, Kovacevic, Zaklina, Khan, Irfan Ullah, Richardson, Des R

    Published in Inorganic chemistry (21-10-2019)
    “…A series of eight bis­(thiosemicarbazone) ligands and 16 of their respective copper­(II) and zinc­(II) complexes containing a combination of hydrogen, methyl,…”
    Get full text
    Journal Article
  6. 6

    Dinuclear zinc bis(thiosemicarbazone) complexes: Synthesis, in vitro anticancer activity, cellular uptake and DNA interaction study by Palanimuthu, Duraippandi, Samuelson, Ashoka G.

    Published in Inorganica Chimica Acta (01-11-2013)
    “…A series of new dinuclear zinc complexes based on bis(thiosemicarbazone) ligands has been synthesized. Their anticancer activity was screened against five…”
    Get full text
    Journal Article
  7. 7

    Zinc(II)–Thiosemicarbazone Complexes Are Localized to the Lysosomal Compartment Where They Transmetallate with Copper Ions to Induce Cytotoxicity by Stacy, Alexandra E, Palanimuthu, Duraippandi, Bernhardt, Paul V, Kalinowski, Danuta S, Jansson, Patric J, Richardson, Des R

    Published in Journal of medicinal chemistry (26-05-2016)
    “…As the di-2-pyridylketone thiosemicarbazone (DpT) and 2-acetylpyridine thiosemicarbazone (ApT) series show potent antitumor activity in vitro and in vivo, we…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Inhibition and kinetic studies of phytochemical constituents of Goniothalamus wynaadensis and their isoxazoline derivatives on α-glucosidase by Bojja, Kavya Sritha, Kumar, Akash, Palanimuthu, Duraippandi, Holla, Harish, Gawli, Kavishankar

    Published in Natural product research (17-05-2024)
    “…α-Glucosidase, an enzyme involved in post-prandial hyperglycaemia, was used as a target to study the effect of compound(s) isolated from and its isoxazoline…”
    Get full text
    Journal Article
  10. 10

    A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer's disease by Palanimuthu, Duraippandi, Poon, Rachal, Sahni, Sumit, Anjum, Rukhsana, Hibbs, David, Lin, Hsuan-Yu, Bernhardt, Paul V., Kalinowski, Danuta S., Richardson, Des R.

    Published in European journal of medicinal chemistry (20-10-2017)
    “…Over 44 million people live with Alzheimer's disease (AD) worldwide. Currently, only symptomatic treatments are available for AD and no cure exists…”
    Get full text
    Journal Article
  11. 11

    Copper and conquer: copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics by Park, Kyung Chan, Fouani, Leyla, Jansson, Patric J, Wooi, Danson, Sahni, Sumit, Lane, Darius J. R, Palanimuthu, Duraippandi, Lok, Hiu Chuen, Kova evi, Zaklina, Huang, Michael L. H, Kalinowski, Danuta S, Richardson, Des R

    Published in Metallomics (01-09-2016)
    “…Copper is an essential trace metal required by organisms to perform a number of important biological processes. Copper readily cycles between its reduced Cu( i…”
    Get full text
    Journal Article
  12. 12

    Novel multifunctional iron chelators of the aroyl nicotinoyl hydrazone class that markedly enhance cellular NAD+/NADH ratios by Wu, Zhixuan, Palanimuthu, Duraippandi, Braidy, Nady, Salikin, Nor Hawani, Egan, Suhelen, Huang, Michael L.H., Richardson, Des R.

    Published in British journal of pharmacology (01-05-2020)
    “…Background and Purpose Alzheimer's disease (AD) is a multifactorial condition leading to cognitive decline and represents a major global health challenge in…”
    Get full text
    Journal Article
  13. 13

    A novel zinc bis(thiosemicarbazone) complex for live cell imaging by Dayal, Disha, Palanimuthu, Duraippandi, Shinde, Sridevi Vijay, Somasundaram, Kumaravel, Samuelson, Ashoka G.

    Published in Journal of biological inorganic chemistry (01-04-2011)
    “…Fluorescent zinc complexes have recently attracted a lot of interest owing to their vast applications in cellular imaging. We report the synthesis as well as…”
    Get full text
    Journal Article
  14. 14

    The use of iron chelators in biocidal compositions: evaluation of patent, WO2014059417A1 by Sahni, Sumit, Krishan, Sukriti, Palanimuthu, Duraippandi, Richardson, Des R

    Published in Expert opinion on therapeutic patents (01-03-2015)
    “…Anti-microbial-potentiating compositions, containing one or more anti-microbial agents and an iron chelator, are claimed in the patent application. Different…”
    Get more information
    Journal Article